Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-37.44M
↑ 79% above average
Average (9y)
$-178.54M
Historical baseline
Range
High:$-37.44M
Low:$-306.26M
CAGR
-10.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-37.44M | +51.1% |
| 2023 | $-76.53M | +55.1% |
| 2022 | $-170.34M | +17.5% |
| 2021 | $-206.38M | +12.7% |
| 2020 | $-236.52M | +12.5% |
| 2019 | $-270.43M | +11.7% |
| 2018 | $-306.26M | -39.2% |
| 2017 | $-220.01M | -40.6% |
| 2016 | $-156.49M | -49.1% |
| 2015 | $-104.96M | - |